Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TO IMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS.

Issued by NATIONAL INSTITUTES OF HEALTH · NATIONAL INSTITUTES OF HEALTH OLAO

Sol. 75N98026Q00392PresolicitationBETHESDA, MD

Closed

STATUS

Closed

closed Jun 3, 2026

POSTED

May 19, 2026

Publication date

NAICS CODE

622110

Primary industry classification

PSC CODE

R499

Product & service classification

AI Summary

The Department of Health and Human Services is seeking modifications to the A11 HERV-E TCR and T cell product to enhance therapeutic efficacy for patients with clear cell renal cell carcinoma (CCRCC). This presolicitation indicates a sole source intent, inviting proposals for innovative solutions in biotechnology and therapeutic products.

Contract details

Solicitation No.: 75N98026Q00392
Notice Type: Presolicitation
Posted Date: May 19, 2026
Response Deadline: June 3, 2026
NAICS Code: 622110 AI guide
PSC / Class Code: R499
Issuing Office: NATIONAL INSTITUTES OF HEALTH OLAO
Sub-Agency: NATIONAL INSTITUTES OF HEALTH
Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES
Primary Contact: FALZONE, MICHAEL L
City: BETHESDA
State: MD
ZIP Code: 20892
AI Product/Service: both

Description

Attachment: Notice of Intent to Sole Source

Key dates

May 19, 2026Posted Date
June 3, 2026Proposals / Responses Due

AI search tags

healthcare services biotechnology therapeutic products cancer treatment

Frequently asked questions

MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TO IMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS. is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

SamSearch Platform

Stop searching. Start winning.

AI-powered intelligence for the right opportunities, the right leads, and the right time.

Book a Demo